JPMorgan Boosts Price Target on Essex Property Trust ESS Amid Strong Apartment Demand Novartis Lifts FullYear Sales and Profit Guidance Amid Strong Operational Performance The Secretive Business of Orchid Breeding A DecadeLong Investment with Lucrative Potential Jim Cramers OnAir Silence Trumps 3700 Stock Trades Expose Potential Conflict of Interest Concerns Chinas Robot Workforce Strategy Elon Musk Highlights Humanoid Robotics Competition UK Bank Holiday Heatwave and Travel Disruptions Could Impact Travel Sector PONY Q4 2025 Earnings Narrowing Losses Beat Estimates as Stock Edges Lower KFS Q1 2026 Earnings Loss Per Share of 010 Reported Stock Down Slightly Textron Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction Marine Products Corporation MPX Q1 2026 Earnings Weak Profitability and Stock Decline Highlight Ongoing Challenges GOGO Q1 2026 Earnings Profitability Surprises as EPS Beats Estimates HFWA Q1 2026 Earnings Net Interest Margin Stability Drives Earnings Beat Hub Cyber Security Warrants HUBCW Edge Higher Amid Thin Trading Hold at Penny Level Cheetah Net Supply Chain Service Inc CTNT Faces Minor Pullback Holds Above Key Support SuperCom Ltd SPCB Shows Modest Gains Amid Support Test American Electric Power AEP Advances 153 as Utility Sector Holds Steady Excelerate Energy EE Declines 358 as Shares Test Key Support Zone Michael Saylors MicroStrategy A Potential Shift in Bitcoin Accumulation Strategy Genpact G Q1 2026 Earnings EPS Beat Drives Investor Focus on Margin Strength Prudential Financial Junior Subordinated Notes PRS Nears Support as Yields Attract Consideration JSM Q1 2026 Earnings Navient Beats EPS Estimates by 2225 Note Price Unchanged Piper Sandler Q1 2026 Earnings EPS Beats Estimates by 512 Amid Mixed Market Signals SOWG Q3 2025 Earnings Significant EPS Miss Highlights Operational Challenges ULTA Q1 2026 Earnings EPS Misses Estimates But Stock Gains A Mixed Start to Fiscal 2026 SANUWAVE Health Inc Q1 2026 Earnings Significant EPS Miss Leads to Stock Decline NGNE Q1 2026 Earnings EPS Falls Short of Consensus as PreRevenue Biotech Maintains RD Focus CACC Q1 2026 Earnings EPS Slightly Misses Estimates Amid Steady Operations